Valvular & structural heart diseaseCohort study

Measured Versus Predicted Prosthesis–Patient Mismatch after TAVR in Sievers Type 1 BAV: Incidence, Determinants, and Outcomes From the AD-HOC Registry

Circ Cardiovasc IntervPublished

  • retrospective, multicenter study
  • 24 centers

Authors' conclusion

In patients with Sievers type 1 bicuspid aortic valve undergoing transcatheter aortic valve replacement, pPPM occurred less frequently than mPPM and was predominantly driven by anatomic characteristics and sizing strategies. Although pPPM was associated with increased all-cause mortality among patients with small annuli, this association did not extend to cardiovascular mortality and should be considered hypothesis-generating. Further prospective investigations are warranted to better delineate the impact of anatomic constraints on clinical outcomes in this anatomically challenging subset.

Study context

Population
Patients with severe aortic stenosis and Sievers type 1 bicuspid aortic valve treated with transcatheter aortic valve replacement between 2016 and 2023
Participants
781 patients
Exposure
Measured versus predicted prosthesis-patient mismatch
Outcome
All-cause mortality
Follow-up
Mean 621±470 days

Main finding

As reported in the abstract

  • neither mPPM nor pPPM was associated with mortality in the overall cohort

Observational data: associations, not effects.

Further findings

Moderate-to-severe PPM incidence

  • Moderate-to-severe prosthesis-patient mismatch (PPM) incidence: P <0.001

Predictors of PPM

Balloon-expandable valves were independently associated with both mPPM and pPPM
smaller valve size and supra-annular sizing predicted only pPPM

pPPM in patients with a small annulus (≤430 mm 2 ; n=145)

pPPM occurrence was significantly higher
19% versus 5.5%
associated with increased all-cause mortality, but not with cardiovascular mortality
  • P <0.001
  • subgroup: small annulus (≤430 mm 2 ; n=145)

Original publication

Measured Versus Predicted Prosthesis–Patient Mismatch after TAVR in Sievers Type 1 BAV: Incidence, Determinants, and Outcomes From the AD-HOC Registry. Circ Cardiovasc Interv. Published 12 May 2026. doi:10.1161/circinterventions.125.015994

Summarised from the published abstract; every number is checked against it